HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
Search Tool Menu
HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
Menu
Close Button
Leadership


Vincent Fert
Executive Vice President, Immuno-Oncology and EU Operations

Vincent Fert has extensive diagnostic leadership experience, most recently serving as the Founder, Chairman and Chief Executive Officer of HalioDx, an immuno-oncology diagnostics company recently acquired by Veracyte.

A serial entrepreneur, Mr. Fert was formerly a member of the board and Chief Executive Officer of Qiagen Marseille and Vice President, Personalized Healthcare Care Program Lead for Qiagen N.V. In 1999, he founded Ipsogen, which became a leader in the molecular diagnosis of leukemia and an Alternext-listed company before being acquired by Qiagen in 2011.

Mr. Fert was formerly an R&D lead at Beckman Coulter and Immunotech. He holds a degree in Immunology from Aix-Marseille University.